N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺

N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺性质、用途与生产工艺

概述

N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺 上下游产品信息

上游原料

下游产品

N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺 生产厂家

558447-26-0, N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺 相关搜索:

• 抑制剂
• 医药原料
• 标准品
• G蛋白偶联受体&G蛋白
• AMD-070 (AMD-11070)
• 化合物AMD-070,10 MM DMSO 溶液
• (S)-N1-((1H-苯并[D]咪唑-2-基)甲基)-N1-(5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺
• X4P-001
• 化合物AMD-070
• N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺
• (S)-N1-((1H-苯并[D]咪唑基-2-基)甲基)-N1-(5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺
• 558447-26-0
• AMD-070 (AMD-11070)
• Mavorixafor, 10 mM in DMSO
• Mavorixafor (AMD-070, X4P-001)
• Mavorixafor,CXCR,AMD 070,Human immunodeficiency virus,AMD070,HIV,inhibit,CXC chemokine receptors,Inhibitor
• Mavorixafor(AMD-070)
• Mavorixafor
• N'-(1h-benzimidazol-2-ylmethyl)-n'-[(8s)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine
• 1,4-Butanediamine, N1-(1H-benzimidazol-2-ylmethyl)-N1-[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]-
• (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diami
• AMD070/AMD-070
• (S)-N1-((1H-benzo[d]iMidazol-2-yl)Methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diaMine
• 1,4-ButanediaMine, N-(1H-benziMidazol-2-ylMethyl)-N-[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]-
• AMD 070 N-(1H-benziMidazol-2-ylMethyl)-N-[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]- (9CI)
• N'-(1H-Benzimidazol-2-ylmethyl)-N'-((S)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
• N-(1H-benzimidazol-2-ylmethyl)-N-[(8S)-5,6,7,8-tetrahydro-8-quinolinyl]- (9CI)
• AMD-11070
• AMD 070